{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:04:03Z","timestamp":1788433443107,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jcv.2024.105717","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T19:59:10Z","timestamp":1721851150000},"page":"105717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["HIV-1 genotypic resistance testing using single molecule real-time sequencing"],"prefix":"10.1016","volume":"174","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3780-5844","authenticated-orcid":false,"given":"St\u00e9phanie","family":"Raymond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Jeanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Vellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Nicot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Saune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"Ranger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Latour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Carcenac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Harter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Delobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Izopet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2024.105717_bib0001","doi-asserted-by":"crossref","first-page":"6824","DOI":"10.1128\/AAC.01490-15","article-title":"HIV drug resistance testing by high-multiplex \u201cwide\u201d sequencing on the MiSeq instrument","volume":"59","author":"Lapointe","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jcv.2024.105717_bib0002","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jviromet.2015.04.022","article-title":"Performance assessment of the Illumina massively parallel sequencing platform for deep sequencing analysis of viral minority variants","volume":"221","author":"Thys","year":"2015","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jcv.2024.105717_bib0003","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/QAD.0000000000000267","article-title":"Comparison of ultra-deep versus Sanger sequencing detection of minority mutations on the HIV-1 drug resistance interpretations after virological failure","volume":"28","author":"Mohamed","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.jcv.2024.105717_bib0004","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/cid\/cit125","article-title":"Clinical implications of HIV-1 minority variants","volume":"56","author":"Li","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2024.105717_bib0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/QAD.0b013e32834e9d7d","article-title":"Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure","volume":"26","author":"Li","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.jcv.2024.105717_bib0006","first-page":"672","article-title":"Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patients","volume":"201","author":"Halvas","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2024.105717_bib0007","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00126334-200501010-00007","article-title":"Detection of minority populations of HIV-1 expressing the K103N resistance mutation in patients failing nevirapine","volume":"38","author":"Lecossier","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jcv.2024.105717_bib0008","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.virol.2012.01.002","article-title":"Ultra-deep sequencing of HIV-1 reverse transcriptase before start of an NNRTI-based regimen in treatment-naive patients","volume":"426","author":"Messiaen","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.jcv.2024.105717_bib0009","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/jac\/dkac391","article-title":"HIV-1 resistance genotyping by ultra-deep sequencing and 6-month virological response to first-line treatment","volume":"78","author":"Raymond","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jcv.2024.105717_bib0010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12977-014-0122-8","article-title":"Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq","volume":"11","author":"Dudley","year":"2014","journal-title":"Retrovirology"},{"key":"10.1016\/j.jcv.2024.105717_bib0011","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jviromet.2014.11.003","article-title":"Evaluation of GS Junior and MiSeq next-generation sequencing technologies as an alternative to Trugene population sequencing in the clinical HIV laboratory","volume":"212","author":"Ram","year":"2015","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jcv.2024.105717_bib0012","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dky003","article-title":"HIV-1 genotypic resistance testing using the Vela automated next-generation sequencing platform","author":"Raymond","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jcv.2024.105717_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2019.104229","article-title":"Performance evaluation of the Vela Dx Sentosa next-generation sequencing system for HIV-1 DNA genotypic resistance","volume":"122","author":"Raymond","year":"2020","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2024.105717_bib0014","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/jac\/dky561","article-title":"Detection of pretreatment minority HIV-1 reverse transcriptase inhibitor-resistant variants by ultra-deep sequencing has a limited impact on virological outcomes","volume":"74","author":"Su","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jcv.2024.105717_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2023.105491","article-title":"Full-spectrum HIV drug resistance mutation detection by high-resolution complete pol gene sequencing","volume":"164","author":"Faraci","year":"2023","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2024.105717_bib0016","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1097\/QAD.0000000000002697","article-title":"Resistance profile of HIV-1 quasispecies in patients under treatment failure using single molecule, real-time sequencing","volume":"34","author":"Monaco","year":"2020","journal-title":"AIDS"},{"key":"10.1016\/j.jcv.2024.105717_bib0017","doi-asserted-by":"crossref","DOI":"10.7448\/IAS.18.1.20035","article-title":"Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management","volume":"18","author":"Grossmann","year":"2015","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.jcv.2024.105717_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2019.104207","article-title":"Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay","volume":"121","author":"Alidjinou","year":"2019","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2024.105717_bib0019","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1016\/S2352-3018(18)30177-2","article-title":"PanAfrican studies to evaluate resistance, clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study","volume":"5","author":"Inzaule","year":"2018","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jcv.2024.105717_bib0020","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1016\/S2352-3018(16)30119-9","article-title":"HIVDR MexNet Group, Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey","volume":"3","author":"\u00c1vila-R\u00edos","year":"2016","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jcv.2024.105717_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2024.105639","article-title":"Portable Nanopore sequencing solution for next-generation HIV drug resistance testing","volume":"171","author":"Park","year":"2024","journal-title":"J. Clin. Virol."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653224000799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653224000799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T16:47:53Z","timestamp":1728492473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653224000799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":21,"alternative-id":["S1386653224000799"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2024.105717","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV-1 genotypic resistance testing using single molecule real-time sequencing","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2024.105717","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105717"}}